No title
In a low inflammatory skin environment, Langerhans cells (LCs)– but not dermal dendritic cells (dDCs)– contribute to the pivotal process of tolerance induction. Thus LCs are a target for specific-tolerance therapies. LCs reside just below the stratum corneum, within the skin's viable epidermis. One way to precisely deliver immunotherapies to LCs while remaining minimally invasive is with a skin de
